CSEIX | SREYX | CSEIX / SREYX | |
Total Expense Ratio | 1.10 | 0.99 | 111% |
Annual Report Gross Expense Ratio | 1.10 | 0.99 | 111% |
Fund Existence | 28 years | 11 years | - |
Gain YTD | 4.263 | 2.695 | 158% |
Front Load | 5% | N/A | - |
Min. Initial Investment | 0 | 100000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.35B | 72.9M | 11,458% |
Annual Yield % from dividends | 2.72 | 3.12 | 87% |
Returns for 1 year | -1.84 | -1.55 | 119% |
Returns for 3 years | 32.55 | 33.66 | 97% |
Returns for 5 years | 27.20 | 25.09 | 108% |
Returns for 10 years | 55.25 | 4.65 | 1,187% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RICGX | 67.75 | 0.36 | +0.53% |
American Funds Invmt Co of Amer R6 | |||
BRWTX | 29.14 | N/A | N/A |
MFS Blended Research Growth Eq R3 | |||
NPSGX | 18.26 | N/A | N/A |
Nicholas Partners Small Cap Gr Instl | |||
JGYCX | 13.48 | N/A | N/A |
JHancock Global Shareholder Yield C | |||
JFNCX | 61.87 | N/A | N/A |
Janus Henderson Global Life Sciences C |